Sana Biotechnology Inc (SANA) Stock Forecast & Price Target
Sana Biotechnology Inc · NASDAQ
$3.44-0.41 (-10.52%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Sana Biotechnology Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $6.00 to $8.00, so the covering firms are broadly aligned. The average target of $7.00 sits 103% above the current $3.44. The rating mix has stayed broadly stable, with Buy-side ratings easing from 5 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.20 next quarter toward $-0.56 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Strong Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Sana Biotechnology Inc.
As of Sep, 4 of 4 firms rate SANA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
SANA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.20
Range $-0.20 – $-0.20 · 1 analysts · +25% YoY
Next period, 1 analysts expect Sana Biotechnology Inc to earn $-0.20 a share (range $-0.20 – $-0.20), versus $-0.16 a year earlier. Full-year consensus is $-0.59, growing to $-0.56 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Sana Biotechnology Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SANA.
#1
Roger Song
Jefferies · Rank #101
Buy
$7.00+103.2% to target
Overall win rate
43%
+ Follow
#2
Reni J. Benjamin
JMP Securities · Rank #366
Buy
$8.00+132.2% to target
Overall win rate
32%
+ Follow
#3
Emily Bodnar
HC Wainwright & Co. · Rank #399
Buy
$7.00+103.2% to target
Overall win rate
23%
+ Follow
#4
MF
Marc Frahm
TD Cowen
Buy
$2027.00+58738.9% to target
Coverage
—
+ Follow
#5
MF
Martin Fan
Wedbush
Buy
$7.00+103.2% to target
Coverage
—
+ Follow
SANA stock forecast FAQ
What is SANA's average 12-month price target?+
The 4 analysts with a live target average $7.00 for Sana Biotechnology Inc over the next 12 months, ranging from a $8.00 high to a $6.00 low.
Is SANA stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for SANA?+
The Street-high target is $8.00 (Citizens), and the Street-low is $6.00 (B of A Securities). The average of all 4 active targets is $7.00.
How many Wall Street analysts cover SANA?+
4 analysts have an active rating on Sana Biotechnology Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering SANA?+
Among analysts who currently cover SANA, Roger Song of Jefferies has the strongest overall Quantellect track record (Rank #101). Their current call is Buy with a $7.00 target.
What is Sana Biotechnology Inc's projected EPS for next quarter?+
The consensus estimate is $-0.20 per share (range $-0.20 – $-0.20) across 1 analysts. Full-year EPS is projected at $-0.59, rising to $-0.56 the following year.
How much revenue is Sana Biotechnology Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading SANA lately?+
As of Sep, 4 of 4 firms rate SANA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SANA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
